Dolby Laboratories, Inc.
For the period ended Mar 27, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 27, 2026 · Filed Apr 30, 2026
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveLoss | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
|---|---|---|---|---|---|---|---|
| Balance as of December 26, 2025 | $94 | $— | $2,604,358 | $(10,777) | $2,593,675 | $9,196 | $2,602,871 |
| Net income | — | — | 94,915 | — | 94,915 | 539 | 95,454 |
| Other comprehensive loss, net of tax | — | — | — | (1,499) | (1,499) | (36) | (1,535) |
| Distributions to noncontrolling interest | — | — | — | — | — | (559) | (559) |
| Stock-based compensation expense | — | 30,708 | — | — | 30,708 | — | 30,708 |
| Capitalized stock-based compensation expense | — | 77 | — | — | 77 | — | 77 |
| Repurchase of common stock | (1) | (30,235) | (34,763) | — | (64,999) | — | (64,999) |
| Excise tax on common stock repurchases | — | (564) | — | — | (564) | — | (564) |
| Cash dividends declared and paid on common stock | — | — | (34,335) | — | (34,335) | — | (34,335) |
| Common stock issued under employee stock plans | 1 | 1,039 | — | — | 1,040 | — | 1,040 |
| Tax withholdings on vesting of restricted stock | (1) | (1,025) | — | — | (1,026) | — | (1,026) |
| Balance as of March 27, 2026 | $93 | $— | $2,630,175 | $(12,276) | $2,617,992 | $9,140 | $2,627,132 |
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveIncome/(Loss) | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
|---|---|---|---|---|---|---|---|
| Balance as of September 26, 2025 | $94 | $— | $2,634,980 | $(12,517) | $2,622,557 | $9,389 | $2,631,946 |
| Net income | — | — | 148,242 | — | 148,242 | 893 | 149,135 |
| Other comprehensive income/(loss), net of tax | — | — | — | 241 | 241 | (36) | 205 |
| Distributions to noncontrolling interest | — | — | — | — | — | (1,106) | (1,106) |
| Stock-based compensation expense | — | 67,919 | — | — | 67,919 | — | 67,919 |
| Capitalized stock-based compensation expense | — | 204 | — | — | 204 | — | 204 |
| Repurchase of common stock | (2) | (50,629) | (84,373) | — | (135,004) | — | (135,004) |
| Excise tax on common stock repurchases | — | (564) | — | — | (564) | — | (564) |
| Cash dividends declared and paid on common stock | — | — | (68,674) | — | (68,674) | — | (68,674) |
| Common stock issued under employee stock plans | 2 | 15,291 | — | — | 15,293 | — | 15,293 |
| Tax withholdings on vesting of restricted stock | (1) | (32,221) | — | — | (32,222) | — | (32,222) |
| Balance as of March 27, 2026 | $93 | $— | $2,630,175 | $(12,276) | $2,617,992 | $9,140 | $2,627,132 |
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | Accumulated Other Comprehensive Income/(Loss) | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
|---|---|---|---|---|---|---|---|
| Balance as of December 27, 2024 | $95 | $— | $2,543,413 | $(35,542) | $2,507,966 | $9,062 | $2,517,028 |
| Net income | — | — | 91,793 | — | 91,793 | 433 | 92,226 |
| Other comprehensive income, net of tax | — | — | — | 7,564 | 7,564 | 96 | 7,660 |
| Distributions to noncontrolling interest | — | — | — | — | — | (241) | (241) |
| Stock-based compensation expense | — | 30,664 | — | — | 30,664 | — | 30,664 |
| Capitalized stock-based compensation expense | — | 53 | — | — | 53 | — | 53 |
| Repurchase of common stock | (1) | (33,173) | (1,825) | — | (34,999) | — | (34,999) |
| Cash dividends declared and paid on common stock | — | — | (31,829) | — | (31,829) | — | (31,829) |
| Common stock issued under employee stock plans | 1 | 3,966 | — | — | 3,967 | — | 3,967 |
| Tax withholdings on vesting of restricted stock | — | (1,510) | — | — | (1,510) | — | (1,510) |
| Balance as of March 28, 2025 | $95 | $— | $2,601,552 | $(27,978) | $2,573,669 | $9,350 | $2,583,019 |
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | Accumulated Other Comprehensive Loss | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
|---|---|---|---|---|---|---|---|
| Balance as of September 27, 2024 | $94 | $— | $2,496,255 | $(19,187) | $2,477,162 | $9,731 | $2,486,893 |
| Net income | — | — | 159,615 | — | 159,615 | 681 | 160,296 |
| Other comprehensive loss, net of tax | — | — | — | (8,791) | (8,791) | (81) | (8,872) |
| Distributions to noncontrolling interest | — | — | — | — | — | (981) | (981) |
| Stock-based compensation expense | — | 66,734 | — | — | 66,734 | — | 66,734 |
| Capitalized stock-based compensation expense | — | 151 | — | — | 151 | — | 151 |
| Repurchase of common stock | (1) | (59,074) | 9,076 | — | (49,999) | — | (49,999) |
| Cash dividends declared and paid on common stock | — | — | (63,377) | — | (63,377) | — | (63,377) |
| Common stock issued under employee stock plans | 2 | 26,122 | — | — | 26,124 | — | 26,124 |
| Tax withholdings on vesting of restricted stock | — | (33,933) | (17) | — | (33,950) | — | (33,950) |
| Balance as of March 28, 2025 | $95 | $— | $2,601,552 | $(27,978) | $2,573,669 | $9,350 | $2,583,019 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.